Featured Research

from universities, journals, and other organizations

Vaccine risk to myasthenia gravis patients may be worth taking

Date:
October 16, 2013
Source:
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
Summary:
First step taken in collection of data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

A study presented at the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is considered a good first step in collecting data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

"This research is important because there is very little existing data to guide physicians in recommending vaccination for patients with myasthenia gravis," said Andrew Tarulli, MD, AANEM News Science Editorial Board member.

"Physicians, particularly primary care physicians, may undervaccinate their myasthenic patients because they may be concerned about the possibility of provoking an exacerbation. On the contrary, failure to vaccinate a patient may result in pneumonia or influenza, both of which are common precipitants of myasthenia exacerbations or even myasthenic crises," said Dr. Tarulli.

The AANEM committee members reviewing the research agreed that it is a good first step in collecting data on vaccine-preventable illnesses and should be followed by studies documenting the safety of vaccination conducted in larger cohorts. The ultimate goal would be to produce a set of guidelines for neuromuscular physicians who treat myasthenics.

The study, entitled, Prevalence of Vaccine Preventable Infections in Myasthenia Gravis and its Exacerbations, was conducted by Crystal Dixon, MD, a neurology resident at the University of South Florida. Dr. Dixon received the Best Abstract Runner-Up award from the AANEM for her research.


Story Source:

The above story is based on materials provided by American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Note: Materials may be edited for content and length.


Cite This Page:

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). "Vaccine risk to myasthenia gravis patients may be worth taking." ScienceDaily. ScienceDaily, 16 October 2013. <www.sciencedaily.com/releases/2013/10/131016095734.htm>.
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). (2013, October 16). Vaccine risk to myasthenia gravis patients may be worth taking. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2013/10/131016095734.htm
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). "Vaccine risk to myasthenia gravis patients may be worth taking." ScienceDaily. www.sciencedaily.com/releases/2013/10/131016095734.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins